Skip to main content
Top
Published in:

01-12-2024 | Research

An Institutional Experience of Core Needle Biopsy with Cooperative Implementation by Pathologists and Head and Neck Oncologists in Salivary Gland Carcinoma

Authors: Kenya Kobayashi, Seiichi Yoshimoto, Go Omura, Yoshifumi Matsumoto, Azusa Sakai, Kohtaro Eguchi, Toshihiko Sakai, Yoshitaka Honma, Fumihiko Matsumoto, Masahito Kawazu, Yuki Saito, Eigitsu Ryo, Akihiko Yoshida, Yasushi Yatabe, Taisuke Mori

Published in: Head and Neck Pathology | Issue 1/2024

Login to get access

Abstract

Purpose

A major problem in establishing treatment strategies for salivary gland carcinomas is the difficulty of preoperative histologic subtyping. Core needle biopsy (CNB) allows the collection of a small, intact specimens from the tumor center for detailed analysis. We evaluated the efficacy and limitations of preoperative diagnosis with CNB specimens collected using a newly developed 20-gauge needle designed to popularize its use.

Methods

Paired preoperative CNB and surgical specimens from 41 patients with malignant salivary gland tumors were retrospectively reviewed. A histologic typing platform, including morphologic and immunohistochemical evaluation and fluorescence in situ hybridization, was evaluated using CNB specimens. Biopsy specimen quality, diagnostic accuracy, and immunohistochemistry concordance rates between biopsy and surgical specimens were analyzed.

Results

In 39 of the 41 patients, CNB provided high-quality specimens, enabling adequate morphologic, immunohistologic, and genomic analyses. In two patients, high-quality CNB specimens could not be obtained due to cystic fluid and tumor firmness. The overall accuracy of correct preoperative diagnosis was 75%. The success rate of histologic subtyping and HER2 immunostaining concordance between CNB and surgical specimens was lower in carcinoma ex-pleomorphic adenoma (CXPA) than in de novo carcinoma (histologic subtyping; CXPA vs de novo carcinoma 50% vs 89%, p = 0.016, HER2 concordance; salivary duct carcinoma [SDC] ex-PA vs de novo SDC 16% vs 100%, p = 4.66E−03). No recurrence occurred due to tumor seeding after CNB.

Conclusions

Highly accurate histologic subtyping of salivary gland carcinomas can be performed by preoperative CNB; however, specificity can be more challenging in pathologically heterogenous tumors.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bishop JA (2022) Proceedings of the north America society of head and neck pathology, Los Angeles, CA March 20, 2022: emerging entities in salivary gland tumor pathology. Head Neck Pathol 16:179–189CrossRefPubMedPubMedCentral Bishop JA (2022) Proceedings of the north America society of head and neck pathology, Los Angeles, CA March 20, 2022: emerging entities in salivary gland tumor pathology. Head Neck Pathol 16:179–189CrossRefPubMedPubMedCentral
2.
go back to reference Justin AB, Lester DRT, Paul EW, Ilan W (2021) Tumors of the salivary glands. AFIP atlas of tumor and nontumor pathology, vol 5. American Registry of Pathology Press, Rockville Justin AB, Lester DRT, Paul EW, Ilan W (2021) Tumors of the salivary glands. AFIP atlas of tumor and nontumor pathology, vol 5. American Registry of Pathology Press, Rockville
3.
go back to reference Kobayashi K, Saito Y, Kage H, Fukuoka O, Yamamura K, Mukai T, Oda K, Yamasoba T (2023) CDK12 alterations and ARID1A mutations are predictors of poor prognosis and therapeutic targets in high-grade salivary gland carcinoma: analysis OD the National Genomic Profiling Databese. Jpn J Clin Oncol 53(9):798–807CrossRefPubMed Kobayashi K, Saito Y, Kage H, Fukuoka O, Yamamura K, Mukai T, Oda K, Yamasoba T (2023) CDK12 alterations and ARID1A mutations are predictors of poor prognosis and therapeutic targets in high-grade salivary gland carcinoma: analysis OD the National Genomic Profiling Databese. Jpn J Clin Oncol 53(9):798–807CrossRefPubMed
4.
go back to reference Birgin E, Yang C, Hetjens S, Reissfelder C, Hohenberger P, Rahbari NN (2020) Core needle biopsy versus incisional biopsy for differentiation of soft-tissue sarcomas: a systematic review and meta-analysis. Cancer 126(9):1917–1928CrossRefPubMed Birgin E, Yang C, Hetjens S, Reissfelder C, Hohenberger P, Rahbari NN (2020) Core needle biopsy versus incisional biopsy for differentiation of soft-tissue sarcomas: a systematic review and meta-analysis. Cancer 126(9):1917–1928CrossRefPubMed
5.
go back to reference Hurry KJ, Karunaratene D, Westley S, Booth A, Ramesar KCRB, Zhang TT, Williams M, Howlett DC (2022) Ultrasound-guided core biopsy in the diagnosis of parotid neoplasia: an overview an update with a review of the literature. Br J Radiol 95(1130):20210972CrossRefPubMed Hurry KJ, Karunaratene D, Westley S, Booth A, Ramesar KCRB, Zhang TT, Williams M, Howlett DC (2022) Ultrasound-guided core biopsy in the diagnosis of parotid neoplasia: an overview an update with a review of the literature. Br J Radiol 95(1130):20210972CrossRefPubMed
6.
go back to reference Orzco JIJ, Chang SC, Matsuba C, Ensenyat-Mendez M, Grunkemeier GL, Marzese DM et al (2021) Is the 221-Gene Recurrence score on core needle biopsy equivalent to surgical specimen in early-stage breast cancer? A comparison of gene expression between paired core needle biopsy and surgical specimens. Ann Surg Oncol 28(10):5588–5596CrossRef Orzco JIJ, Chang SC, Matsuba C, Ensenyat-Mendez M, Grunkemeier GL, Marzese DM et al (2021) Is the 221-Gene Recurrence score on core needle biopsy equivalent to surgical specimen in early-stage breast cancer? A comparison of gene expression between paired core needle biopsy and surgical specimens. Ann Surg Oncol 28(10):5588–5596CrossRef
7.
go back to reference Ohtomo R, Mori T, Shibata S, Tsuta K, Maeshima AM, Akazawa C et al (2013) SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis. Mod Pathol 26(8):1041–1050 Ohtomo R, Mori T, Shibata S, Tsuta K, Maeshima AM, Akazawa C et al (2013) SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis. Mod Pathol 26(8):1041–1050
8.
go back to reference Geiger JL, Ismaila N, Beadle B, Caudell JJ, Chau N, Deschler D et al (2021) Management of salivary gland malignancy: ASCO guideline. J Clin Oncol 39(17):1909–1941CrossRefPubMed Geiger JL, Ismaila N, Beadle B, Caudell JJ, Chau N, Deschler D et al (2021) Management of salivary gland malignancy: ASCO guideline. J Clin Oncol 39(17):1909–1941CrossRefPubMed
9.
go back to reference Head and Neck Tumours WHO Classification of Tumours, 5th edn, WHO Classification of Tumours Editorial Board (2024) 9 ISBN-13 978-92-832-4514-8 Head and Neck Tumours WHO Classification of Tumours, 5th edn, WHO Classification of Tumours Editorial Board (2024) 9 ISBN-13 978-92-832-4514-8
10.
go back to reference Hardra-Luca A, Lamas G, Bertrand JC, Fouret P (2005) MUC1, MUC2, MUC4, MUC5AC expression in salivary gland mucoepidermoid carcinoma: diagnostic and prognostic implications. Am J Surg Pathol 29(7):881–889CrossRef Hardra-Luca A, Lamas G, Bertrand JC, Fouret P (2005) MUC1, MUC2, MUC4, MUC5AC expression in salivary gland mucoepidermoid carcinoma: diagnostic and prognostic implications. Am J Surg Pathol 29(7):881–889CrossRef
11.
go back to reference Wong SJ, Karrison T, Hayes DN, Kies MS, Cullen KJ, Tanvetyanon T et al (2016) Phase II trial of dastinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors. Ann Oncol 27(2):318–323CrossRefPubMed Wong SJ, Karrison T, Hayes DN, Kies MS, Cullen KJ, Tanvetyanon T et al (2016) Phase II trial of dastinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors. Ann Oncol 27(2):318–323CrossRefPubMed
12.
go back to reference Wolff AC, Hammond ME, Hicks DG et al (2014) Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. Arch Pathol Lab Med 138(2):241–256CrossRefPubMed Wolff AC, Hammond ME, Hicks DG et al (2014) Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. Arch Pathol Lab Med 138(2):241–256CrossRefPubMed
13.
go back to reference Takahashi H, Tada Y, Saotome T, Akazawa K, Ojiri H, Fushimi C et al (2019) Phase II trial of trastuzumab and docetaxel in patients with human epidermal growth factor receptor 2-positive salivary duct carcinoma. J Clin Oncol 37(2):125–134CrossRefPubMed Takahashi H, Tada Y, Saotome T, Akazawa K, Ojiri H, Fushimi C et al (2019) Phase II trial of trastuzumab and docetaxel in patients with human epidermal growth factor receptor 2-positive salivary duct carcinoma. J Clin Oncol 37(2):125–134CrossRefPubMed
14.
go back to reference Kanda Y (2013) Investigation of the freely available essy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 48(3):452–458CrossRefPubMed Kanda Y (2013) Investigation of the freely available essy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 48(3):452–458CrossRefPubMed
15.
go back to reference Ho JPK, Mair M, Noor A, Fuzi J, Giles M, Lodbrook I, Hoffman G, Winters R, Cope D, Eisnberg R (2023) Systematic review and meta-analysis on the incidence of level-specific cervival nodal metastasis in primary parotid malignancies. Otolaryngol Head Neck Surg 168(6):1279–1288CrossRefPubMed Ho JPK, Mair M, Noor A, Fuzi J, Giles M, Lodbrook I, Hoffman G, Winters R, Cope D, Eisnberg R (2023) Systematic review and meta-analysis on the incidence of level-specific cervival nodal metastasis in primary parotid malignancies. Otolaryngol Head Neck Surg 168(6):1279–1288CrossRefPubMed
16.
go back to reference Yan F, Lao WP, Nguyen SA, Sharma AK, Day TA (2022) Elective neck dissection in salivary gland malignancies: Systematic reviews and meta-analysis. Head Neck 44(2):505–517CrossRefPubMed Yan F, Lao WP, Nguyen SA, Sharma AK, Day TA (2022) Elective neck dissection in salivary gland malignancies: Systematic reviews and meta-analysis. Head Neck 44(2):505–517CrossRefPubMed
17.
go back to reference Steuer CE, Hanna GJ, Viswanthan K, Bates JE, Kaka AS, Schmitt NC, Ho AL, Saba NF (2023) The evolving landscape of salivary gland tumors. CA Cancer J Clin 73(6):597–619CrossRefPubMedPubMedCentral Steuer CE, Hanna GJ, Viswanthan K, Bates JE, Kaka AS, Schmitt NC, Ho AL, Saba NF (2023) The evolving landscape of salivary gland tumors. CA Cancer J Clin 73(6):597–619CrossRefPubMedPubMedCentral
18.
go back to reference Walsh E, Allan K, Brennan PA, Tullett M, Gomez RS, Rahimi S (2022) Diagnostic accuracy of ultrasonography-guided core needle biopsy of parotid gland neoplasms: a large, single-institution experience in united kingdom. J Oral Pathol Med 51(1):1–4CrossRefPubMed Walsh E, Allan K, Brennan PA, Tullett M, Gomez RS, Rahimi S (2022) Diagnostic accuracy of ultrasonography-guided core needle biopsy of parotid gland neoplasms: a large, single-institution experience in united kingdom. J Oral Pathol Med 51(1):1–4CrossRefPubMed
19.
go back to reference Novoa E, Gurtler N, Arnoux A, Kraft M (2016) Diagnostic value of core needle biopsy and fine-needle aspiration in salivary gland lesions. Head Neck 38(suppl1):E346–E352PubMed Novoa E, Gurtler N, Arnoux A, Kraft M (2016) Diagnostic value of core needle biopsy and fine-needle aspiration in salivary gland lesions. Head Neck 38(suppl1):E346–E352PubMed
20.
go back to reference Thierauf JC, Farahani AA, Indave BI, Bard AZ, Whith VA, Smith CR, Marble H, Hyrcza MD, Chan JKC, Bishop J, Shi Q, Ely K, Agimy A, Martinez-Lage M, Nose V, Rivera M, Nardi V, Dias-Santagata D, Garg S, Sadow P, Le LP, Faquin W, Ritterhouse LL, Cree IA, Iafrate AJ, Lenner JK (2022) Diagnostic value of MAML2 rearrangements in mucoepidermoid carcinoma. Int Mol Sci 23(8):4322CrossRef Thierauf JC, Farahani AA, Indave BI, Bard AZ, Whith VA, Smith CR, Marble H, Hyrcza MD, Chan JKC, Bishop J, Shi Q, Ely K, Agimy A, Martinez-Lage M, Nose V, Rivera M, Nardi V, Dias-Santagata D, Garg S, Sadow P, Le LP, Faquin W, Ritterhouse LL, Cree IA, Iafrate AJ, Lenner JK (2022) Diagnostic value of MAML2 rearrangements in mucoepidermoid carcinoma. Int Mol Sci 23(8):4322CrossRef
21.
go back to reference Nakaguro M, Shadow PM, Hu R, Hattori H, Kuwabara K, Tsuzuki T, Urano M, Nagao T, Faquin WC (2022) NKX3.1 Expression in salivary gland “intraductal” papillary mucinous neoplasm: a low-grade subtaype of salivary gland mucinous adenocarcinoma. Head Neck Pathol 16(4):1114–1123CrossRefPubMedPubMedCentral Nakaguro M, Shadow PM, Hu R, Hattori H, Kuwabara K, Tsuzuki T, Urano M, Nagao T, Faquin WC (2022) NKX3.1 Expression in salivary gland “intraductal” papillary mucinous neoplasm: a low-grade subtaype of salivary gland mucinous adenocarcinoma. Head Neck Pathol 16(4):1114–1123CrossRefPubMedPubMedCentral
22.
go back to reference Gurel B, Ali TZ, Montgomery EA, Begum S, Hicks J, Gogginns M, Eberhart CG, Clark DP, Bieberich CJ, Epstein JI, De Marzo AM (2021) NKX3.1 as a marker of prostatic origin in metastatic tumors. Am J Surg Pathol 34(8):1097–1105CrossRef Gurel B, Ali TZ, Montgomery EA, Begum S, Hicks J, Gogginns M, Eberhart CG, Clark DP, Bieberich CJ, Epstein JI, De Marzo AM (2021) NKX3.1 as a marker of prostatic origin in metastatic tumors. Am J Surg Pathol 34(8):1097–1105CrossRef
23.
go back to reference Nakaguro M, Tanigawa M, Hirai H, Yamatoto Y, Urano M, Takahashi RH, Sukeda A, Okumura Y, Honda S, Tasaki K, Shimazu A, Tukahara K, Tsa Y, Matsubayashi J, Faquin WC, Sadow PM, Nagao T (2021) The diagnostic utility of RAS Q61R mutation-soecific immunoshistochemistry in epithelial-myoepithelial carcinoma. Am J Surg Pathol 45(7):885–894CrossRefPubMedPubMedCentral Nakaguro M, Tanigawa M, Hirai H, Yamatoto Y, Urano M, Takahashi RH, Sukeda A, Okumura Y, Honda S, Tasaki K, Shimazu A, Tukahara K, Tsa Y, Matsubayashi J, Faquin WC, Sadow PM, Nagao T (2021) The diagnostic utility of RAS Q61R mutation-soecific immunoshistochemistry in epithelial-myoepithelial carcinoma. Am J Surg Pathol 45(7):885–894CrossRefPubMedPubMedCentral
24.
go back to reference Viswanathan K, Beg S, He B, Zhang T, Cantley R, Lubin DJ, Shi Q, Maleki Z, Asiry S, Rao R, Katabi N, Nakaguro M, Faquin WC, Sadow PM, Siddiqui MT, Scognamiglio T (2022) NR4A3 immunostain is a highly sensitive and specific marker for acinic cell carcinoma in cytologic and surgical specimens. Am J Clin Pathol 157(1):98–108CrossRefPubMed Viswanathan K, Beg S, He B, Zhang T, Cantley R, Lubin DJ, Shi Q, Maleki Z, Asiry S, Rao R, Katabi N, Nakaguro M, Faquin WC, Sadow PM, Siddiqui MT, Scognamiglio T (2022) NR4A3 immunostain is a highly sensitive and specific marker for acinic cell carcinoma in cytologic and surgical specimens. Am J Clin Pathol 157(1):98–108CrossRefPubMed
25.
go back to reference Jering M, Thölken R, Zenk J (2023) Indications for fine-needle aspiration and core needle biopsy for diagnosis of salivary gland tumors. HNO 71(3):154–163CrossRefPubMed Jering M, Thölken R, Zenk J (2023) Indications for fine-needle aspiration and core needle biopsy for diagnosis of salivary gland tumors. HNO 71(3):154–163CrossRefPubMed
26.
go back to reference Cengiz AB, Tansuker HD, Gul R, Emre F, Demirbas T, Oktay MF (2021) Comparison of preoperative diagnostic accuracy of fine needle aspiration and core needle biopsy in parotid gland neoplasms. Eur Arsh Otorhinolaryngol 278(10):4067–4074CrossRef Cengiz AB, Tansuker HD, Gul R, Emre F, Demirbas T, Oktay MF (2021) Comparison of preoperative diagnostic accuracy of fine needle aspiration and core needle biopsy in parotid gland neoplasms. Eur Arsh Otorhinolaryngol 278(10):4067–4074CrossRef
27.
go back to reference Tabibi S, Gabrielson M, Saoud C, Davis K, Wangsiricharosen S, Lu R et al (2022) Ancillary studies on cell blocks from fine needle aspiration specimens of salivary gland lesions: a multi-institional study. Diagn Cytopathol 50(5):235–252CrossRefPubMedPubMedCentral Tabibi S, Gabrielson M, Saoud C, Davis K, Wangsiricharosen S, Lu R et al (2022) Ancillary studies on cell blocks from fine needle aspiration specimens of salivary gland lesions: a multi-institional study. Diagn Cytopathol 50(5):235–252CrossRefPubMedPubMedCentral
28.
go back to reference Faquin WC, Rossi ED, Baloch Z, Barkan GA, Foschini MP, Kurtycz DFI, Pusztasztaszeri M, Vielh P (2018) The Milan system for reporting salivary gland cytology. Springer, Cham Faquin WC, Rossi ED, Baloch Z, Barkan GA, Foschini MP, Kurtycz DFI, Pusztasztaszeri M, Vielh P (2018) The Milan system for reporting salivary gland cytology. Springer, Cham
29.
go back to reference Rossi ED, Faquin WC, Baloch Z, Barkan GA, Foschini MP, Pusztaszeri M, Vielh P, Kurtycz DFI (2017) The Milan system for reporting salivary gland cytopathology: analysis and suggestions of intial survey. Cancer Cytopathol 125(10):757–766CrossRefPubMed Rossi ED, Faquin WC, Baloch Z, Barkan GA, Foschini MP, Pusztaszeri M, Vielh P, Kurtycz DFI (2017) The Milan system for reporting salivary gland cytopathology: analysis and suggestions of intial survey. Cancer Cytopathol 125(10):757–766CrossRefPubMed
30.
go back to reference Perez-de-Oliveira ME, Louredo BVR, do Amaral-Silva GK, Leite AA, de Almeida OP, Jorge Jr J et al (2023) Cell block preparation ad an adjunctive tool after fine-needle aspiration cytology for screening oral and maxillofacial disease. Oral Surg Oral Med Oral Pathol Oral Radiol 136(3):343–352CrossRefPubMed Perez-de-Oliveira ME, Louredo BVR, do Amaral-Silva GK, Leite AA, de Almeida OP, Jorge Jr J et al (2023) Cell block preparation ad an adjunctive tool after fine-needle aspiration cytology for screening oral and maxillofacial disease. Oral Surg Oral Med Oral Pathol Oral Radiol 136(3):343–352CrossRefPubMed
31.
go back to reference Apple SK, Lowe AC, Rao PN, Shintaku IP, Moatamed NA (2009) Comparison of fluorescent on situ hybridization HER-2/neu results on core needle biopsy and excisional biopsy in primary breast cancer. Mod Pathol 22(9):1151–1159CrossRefPubMed Apple SK, Lowe AC, Rao PN, Shintaku IP, Moatamed NA (2009) Comparison of fluorescent on situ hybridization HER-2/neu results on core needle biopsy and excisional biopsy in primary breast cancer. Mod Pathol 22(9):1151–1159CrossRefPubMed
32.
go back to reference Katabi N, Ghossein R, Ho A, Dogan S, Zhang L, Sung YS, Antonescu CR (2015) Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts. Hum Pathol 46(1):26–33CrossRefPubMed Katabi N, Ghossein R, Ho A, Dogan S, Zhang L, Sung YS, Antonescu CR (2015) Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts. Hum Pathol 46(1):26–33CrossRefPubMed
33.
go back to reference Katabi N, Xu B, Jungbluth AA, Zhang L, Shao SY, Lane J, Ghossein R, Antonessu CR (2018) PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities. Histopahology 72(2):285–293CrossRef Katabi N, Xu B, Jungbluth AA, Zhang L, Shao SY, Lane J, Ghossein R, Antonessu CR (2018) PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities. Histopahology 72(2):285–293CrossRef
34.
go back to reference Meattini I, Bicchierai G, Saieva C, De Benedetto D, Desideri I, Becherini C et al (2017) Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: single-institution experience and revies of published literature. Eur J Surg Oncol 43:642–648CrossRefPubMed Meattini I, Bicchierai G, Saieva C, De Benedetto D, Desideri I, Becherini C et al (2017) Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: single-institution experience and revies of published literature. Eur J Surg Oncol 43:642–648CrossRefPubMed
35.
go back to reference Slostad JA, Yun NK, Schad AE, Warrior S, Fogg LF, Rao R et al (2022) Concordance of breast cancer biomarker testing in core needle biopsy and surgical specimens: a single institution experience. Cancer Med 11(24):4954–4965CrossRefPubMedPubMedCentral Slostad JA, Yun NK, Schad AE, Warrior S, Fogg LF, Rao R et al (2022) Concordance of breast cancer biomarker testing in core needle biopsy and surgical specimens: a single institution experience. Cancer Med 11(24):4954–4965CrossRefPubMedPubMedCentral
36.
go back to reference Apple SK, Lowe AC, Rao PN, Shintaku IP, Moatamed NA (2009) Comparison of fluorescent in situ hybridization HER-2/neu results on core needle biopsy and excisional biopsy in primary breast cancer. Mod Pathol 22(9):1151–1159CrossRefPubMed Apple SK, Lowe AC, Rao PN, Shintaku IP, Moatamed NA (2009) Comparison of fluorescent in situ hybridization HER-2/neu results on core needle biopsy and excisional biopsy in primary breast cancer. Mod Pathol 22(9):1151–1159CrossRefPubMed
37.
go back to reference Cho J, Kim J, Lee JS, Chee CG, Kim Y, Choi SI (2020) Comparison of core needle biopsy and fine-needle aspiration in diagnosis of malignant salivary gland neoplasm: systematic review and meta-analysis. Head Neck 42(10):3041–3050CrossRefPubMed Cho J, Kim J, Lee JS, Chee CG, Kim Y, Choi SI (2020) Comparison of core needle biopsy and fine-needle aspiration in diagnosis of malignant salivary gland neoplasm: systematic review and meta-analysis. Head Neck 42(10):3041–3050CrossRefPubMed
38.
go back to reference Roussel F, Nouvet G (1995) Evaluation of large-needle biopsy for the diagnosis of cancer. Acta Cytol 39(3):449–452PubMed Roussel F, Nouvet G (1995) Evaluation of large-needle biopsy for the diagnosis of cancer. Acta Cytol 39(3):449–452PubMed
39.
go back to reference Shah KS, Ethunandan M (2016) Tumor seeding after fine-needle aspiration and core biopsy of the head and neck—a systematic review. Br J Oral Maxillofac Surg 54(3):260–265CrossRefPubMed Shah KS, Ethunandan M (2016) Tumor seeding after fine-needle aspiration and core biopsy of the head and neck—a systematic review. Br J Oral Maxillofac Surg 54(3):260–265CrossRefPubMed
40.
go back to reference Diaz LK, Wiley EL, Venta LA (1999) Are malignat cells displased by large-gauge needle core biopsy of the breast? AJR Am J Roentgenol 173(5):1303–1313CrossRefPubMed Diaz LK, Wiley EL, Venta LA (1999) Are malignat cells displased by large-gauge needle core biopsy of the breast? AJR Am J Roentgenol 173(5):1303–1313CrossRefPubMed
41.
go back to reference Uribura JL, Vuoto HD, Cogorno L, Isetta JA, Candas G, Imach GC (2006) Local recurrence of breast cancer after skin-sparing mastectomy follosing core needle biopsy: case repotes and rebiew of the literature. Breast J 12(3):194–198CrossRef Uribura JL, Vuoto HD, Cogorno L, Isetta JA, Candas G, Imach GC (2006) Local recurrence of breast cancer after skin-sparing mastectomy follosing core needle biopsy: case repotes and rebiew of the literature. Breast J 12(3):194–198CrossRef
Metadata
Title
An Institutional Experience of Core Needle Biopsy with Cooperative Implementation by Pathologists and Head and Neck Oncologists in Salivary Gland Carcinoma
Authors
Kenya Kobayashi
Seiichi Yoshimoto
Go Omura
Yoshifumi Matsumoto
Azusa Sakai
Kohtaro Eguchi
Toshihiko Sakai
Yoshitaka Honma
Fumihiko Matsumoto
Masahito Kawazu
Yuki Saito
Eigitsu Ryo
Akihiko Yoshida
Yasushi Yatabe
Taisuke Mori
Publication date
01-12-2024
Publisher
Springer US
Published in
Head and Neck Pathology / Issue 1/2024
Electronic ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-024-01725-3